OGI SEC Filings - Organigram Global Inc.- Annual Report, Proxy Statement, Prospectus

Basic Stats

LEI	529900J3EQ1VWW76L728
CIK	1620737

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Organigram Global Inc.

SEC Filings (Chronological Order)

This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.

September 2, 2025	EX-99.1	Organigram Global Releases Landmark Report: Legal Cannabis Added $16B to Canada’s GDP in 2024 New analysis shows cannabis as a national growth engine, aligning with Prime Minister Carney’s One Canadian Economy vision. Organigram Global Releases Landmark Report: Legal Cannabis Added $16B to Canada’s GDP in 2024 New analysis shows cannabis as a national growth engine, aligning with Prime Minister Carney’s One Canadian Economy vision.
September 2, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addres
August 13, 2025	EX-99.2	TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss) Income 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed C TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss) Income 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidated Interim Statements of Cash Flows 4 Notes to the Condensed Consolidated Interim Financial Statements 5 – 21 ORGANIGRAM GLOBAL INC.
August 13, 2025	EX-99.3	Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Beena Goldenberg, Chief Executive Officer of Organigram Global Inc.
August 13, 2025	EX-99.5	Organigram Reports Record Third Quarter Fiscal 2025 Results Second consecutive quarter of record revenue, strong adjusted EBITDA growth, Free Cash Flow, and continued international expansion Organigram Reports Record Third Quarter Fiscal 2025 Results Second consecutive quarter of record revenue, strong adjusted EBITDA growth, Free Cash Flow, and continued international expansion TORONTO, ON, August 13, 2025 - Organigram Global Inc.
August 13, 2025	EX-99.1	Q4-F23 (1) INTRODUCTION This Management’s Discussion and Analysis dated August 13, 2025 (this "MD&A") should be read in conjunction with the unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) of Organigram Global Inc.
August 13, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-388 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address o
August 13, 2025	EX-99.4	Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Greg Guyatt, Chief Financial Officer of Organigram Global Inc.
August 1, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-388 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address o
August 1, 2025	EX-99.1	Organigram to Report Third Quarter Fiscal 2025 Results on August 13, 2025 Organigram to Report Third Quarter Fiscal 2025 Results on August 13, 2025 TORONTO-(BUSINESS WIRE)—August 1, 2025 - Organigram Global Inc.
July 8, 2025	EX-99.1	Organigram Global Scales U.S. Presence with Collective Project Direct-to-Consumer Launch in 25 States and Expansion of Hemp-Derived THC Beverage Portfolio Organigram Global Scales U.S. Presence with Collective Project Direct-to-Consumer Launch in 25 States and Expansion of Hemp-Derived THC Beverage Portfolio Toronto, Ontario – July 8, 2025: Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada’s #1 cannabis company by market share, announced today that its recently acquired beverage business, Collective Project, ha
July 8, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of
June 4, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of
June 4, 2025	EX-99.1	FORM 51-102F3 MATERIAL CHANGE REPORT ITEM 1 - Name and Address of Company Organigram Global Inc. (the "Company") 145 King Street West, Suite 1400 Toronto, ON, M5H 1J8 ITEM 2 - Date of Material Change May 27, 2025 ITEM 3 - News Release The Company iss FORM 51-102F3 MATERIAL CHANGE REPORT ITEM 1 - Name and Address of Company Organigram Global Inc.
May 27, 2025	EX-99.1	Organigram Global Announces CEO Succession Plan Organigram Global Announces CEO Succession Plan •Beena Goldenberg, CEO to retire at the end of the Company’s fiscal year •Board of Directors expresses confidence in the Company’s strategic direction and leadership team •Comprehensive CEO selection process will be initiated to identify a successor Toronto (Business Wire) - May 27, 2025 - Organigram Global Inc.
May 27, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of p
May 12, 2025	EX-99.2	TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss) 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed C TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss) 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidated Interim Statements of Cash Flows 4 Notes to the Condensed Consolidated Interim Financial Statements 5 – 20 ORGANIGRAM GLOBAL INC.
May 12, 2025	EX-99.5	Organigram Reports Record Second Quarter Fiscal 2025 Results Organigram Reports Record Second Quarter Fiscal 2025 Results •Record gross revenue of $102.
May 12, 2025	EX-99.3	Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Beena Goldenberg, Chief Executive Officer of Organigram Global Inc.
May 12, 2025	EX-99.1	Q4-F23 (1) INTRODUCTION This Management’s Discussion and Analysis dated May 12, 2025 (this “MD&A”), should be read in conjunction with the unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) of Organigram Global Inc.
May 12, 2025	EX-99.4	Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Greg Guyatt, Chief Financial Officer of Organigram Global Inc.
May 12, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of p
May 7, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of p
May 7, 2025	EX-99.1	Organigram Global’s Collective Project Wins Big at the 2025 High Spirits Awards in California Wins gold medal for Blood Orange Yuzu & Vanilla and platinum medal for Mango Pineapple & Coconut Organigram Global’s Collective Project Wins Big at the 2025 High Spirits Awards in California Wins gold medal for Blood Orange Yuzu & Vanilla and platinum medal for Mango Pineapple & Coconut Toronto, Ontario – May 7, 2025: Organigram Global Inc.
May 5, 2025	EX-99	Organigram to Report Second Quarter Fiscal 2025 Results on May 12, 2025 Organigram to Report Second Quarter Fiscal 2025 Results on May 12, 2025 TORONTO-(BUSINESS WIRE)- May 2, 2025 - Organigram Global Inc.
May 5, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of p
May 5, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of p
May 5, 2025	EX-99.1	Organigram Global Wins “Exporter of the Year” at the 2025 New Brunswick Export Awards Award recognizes exceptional export growth, product innovation, and global market leadership Organigram Global Wins “Exporter of the Year” at the 2025 New Brunswick Export Awards Award recognizes exceptional export growth, product innovation, and global market leadership Toronto, Ontario – May 5, 2025 Organigram Global Inc.
April 29, 2025	EX-99.1	Organigram Global Congratulates Mark Carney on Election Win Organigram Global Congratulates Mark Carney on Election Win Urges new government to work with industry to help legal cannabis industry fuel Canada’s economic growth Toronto, Ontario – April 29, 2025 Organigram Global Inc.
April 29, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-3888 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of
April 25, 2025	EX-99.1	Organigram Global’s Products Recognized at the CNB Awards SHRED, Edison, and Trailblazer Recognized for Excellence in Branding and Product Innovation Organigram Global’s Products Recognized at the CNB Awards SHRED, Edison, and Trailblazer Recognized for Excellence in Branding and Product Innovation Toronto, Ontario – April 24, 2025 Organigram Global Inc.
April 25, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-3888 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of
April 22, 2025	EX-99.1	Organigram Global Shares Recording of its OG Investor Session OG Investor Session includes presentations from Organigram Global’s senior leadership team, tours of its five state-of-the-art facilities, and a live investor Q&A session Organigram Global Shares Recording of its OG Investor Session OG Investor Session includes presentations from Organigram Global’s senior leadership team, tours of its five state-of-the-art facilities, and a live investor Q&A session TORONTO, Ontario – April 22, 2025 – Organigram Global Inc.
April 22, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-3888 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of
April 16, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-3888 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of
April 16, 2025	EX-99.1	New Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada’s Economic Future New Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada’s Economic Future Clear majority believes Canada’s $7.
April 2, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-3888 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of
April 2, 2025	EX-99.1	Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ TORONTO, Ontario – April 2, 2025 – Organigram Global Inc.
April 1, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-3888 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2025 Commission File Number: 001-38885 ORGANIGRAM GLOBAL INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of
April 1, 2025	EX-99.1	Organigram Enters U.S. Through Acquisition of Collective Project Beverages Acquisition Marks Commercial Market Entry in the Fast-Growing Hemp-Derived THC Beverage Category in the U.S. and the Emerging Canadian Cannabis Beverage Category Organigram Enters U.S. Through Acquisition of Collective Project Beverages Acquisition Marks Commercial Market Entry in the Fast-Growing Hemp-Derived THC Beverage Category in the U.S. and the Emerging Canadian Cannabis Beverage Category Toronto, Ontario, April 1, 2025 – Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada’s #1 cannabis company by market share, i
March 26, 2025	EX-99.1	Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence TORONTO, Ontario - March 26, 2025 – Organigram Holdings Inc.
March 26, 2025	EX-99.2	Certificate of Amendment Loi canadienne sur les sociétés par actionsCanada Business Corporations Act Certificat de modification Organigram Global Inc. 969981-3 Corporate name / Dénomination sociale Corporation number / Numéro de société Hantz Prosper Certificate of Amendment Loi canadienne sur les sociétés par actionsCanada Business Corporations Act Certificat de modification Organigram Global Inc.
March 26, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-3888 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address
March 25, 2025	EX-99.1	Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc. Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc.
March 25, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-3888 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address
March 25, 2025	EX-99.2	ORGANIGRAM HOLDINGS INC. (the “Corporation”) Annual General and Special Meeting of Shareholders Held on March 24, 2025 REPORT OF VOTING RESULTS ORGANIGRAM HOLDINGS INC. (the “Corporation”) Annual General and Special Meeting of Shareholders Held on March 24, 2025 REPORT OF VOTING RESULTS Pursuant to section 11.3 of National Instrument 51-102 – Continuous Disclosure Obligations, this report describes the matters decided at the 2024 annual general and special meeting of shareholders of the Corporation held on March 24, 2025 (the “Meeting”).
March 3, 2025	EX-99.1	NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on March 24, 2025 MANAGEMENT INFORMATION CIRCULAR Dated: February 12, 2025 EX-99.1 Exhibit 99.1 NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on March 24, 2025 and MANAGEMENT INFORMATION CIRCULAR Dated: February 12, 2025 NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on March 24, 2025 NOTICE IS HEREBY GIVEN that an annual general and special meeting (the “Meeting”) of the holders (“Shareholders”) of common shares (“Commo
March 3, 2025	EX-99.3	TSX TRUST Virtual Meeting Guide 1/2 Issuer Name ORGANIGRAM HOLDINGS INC. Meeting Date Time March 24, 2025 10:00AM EST This year we will be conducting a virtual meeting, giving you the opportunity to attend the meeting online, using your smartphone, t Exhibit 99.3 TSX TRUST Virtual Meeting Guide 1/2 Issuer Name ORGANIGRAM HOLDINGS INC. Meeting Date Time March 24, 2025 10:00AM EST This year we will be conducting a virtual meeting, giving you the opportunity to attend the meeting online, using your smartphone, tablet or computer. You will be able to view a live webcast of the Meeting, ask questions and submit your votes in real time (where applic
March 3, 2025	EX-99.2	ORGANIGRAM HOLDINGS INC (the “Corporation”) Annual and Special Meeting March 24, 2025 at 10:00AM (Canada/Eastern Standard) Virtual Meeting at 10am EST (the “Meeting”) Proxy Voting – Guidelines and Conditions 1. THIS PROXY IS SOLICITED BY OR ON BEHALF Exhibit 99.2 ORGANIGRAM HOLDINGS INC (the “Corporation”) Annual and Special Meeting March 24, 2025 at 10:00AM (Canada/Eastern Standard) Virtual Meeting at 10am EST (the “Meeting”) Proxy Voting – Guidelines and Conditions 1. THIS PROXY IS SOLICITED BY OR ON BEHALF OF THE MANAGEMENT OF THE CORPORATION. 2. THIS PROXY SHOULD BE READ IN CONJUNCTION WITH THE MEETING MATERIALS PRIOR TO VOTING. 3. If you
March 3, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-3888 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address
March 3, 2025	EX-99.1	Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment TORONTO, Ontario - March 3, 2025 - Organigram Holdings Inc.
March 3, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-3888 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address
February 11, 2025	EX-99.5	Organigram Reports First Quarter Fiscal 2025 Results Organigram Reports First Quarter Fiscal 2025 Results •17% growth in net revenue to $42.
February 11, 2025	EX-99.2	TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Loss 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidat TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Loss 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidated Interim Statements of Cash Flows 4 Notes to the Condensed Consolidated Interim Financial Statements 5 – 17 ORGANIGRAM HOLDINGS INC.
February 11, 2025	EX-99.3	Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Beena Goldenberg, Chief Executive Officer of Organigram Holdings Inc.
February 11, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addre
February 11, 2025	EX-99.4	Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Greg Guyatt, Chief Financial Officer of Organigram Holdings Inc.
February 11, 2025	EX-99.1	DECEMBER 31, 2024 INTRODUCTION This Management’s Discussion and Analysis dated February 11, 2025 (this “MD&A”), should be read in conjunction with the unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) of Organigram Holdings Inc.
February 5, 2025	EX-99.1	Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025 Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025 TORONTO-(BUSINESS WIRE)—February 4, 2025 -Organigram Holdings Inc.
February 5, 2025	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addre
December 20, 2024	EX-99.6	NOTICE The annual information form was inadvertently filed with the incorrect date on December 18, 2024 and is being re-filed. This replaces the previously filed version. 2024 ANNUAL INFORMATION FORM OF ORGANIGRAM HOLDINGS INC. For the Year Ended Sep Amended NOTICE The annual information form was inadvertently filed with the incorrect date on December 18, 2024 and is being re-filed.
December 20, 2024	40-F/A	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F/A (Amendment No. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F/A (Amendment No. 1) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13(A) OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 Commission File Number 001-38885 ORGANIGRAM HOLDINGS INC. (Exact name of
December 20, 2024	EX-99.2	CERTIFICATION Exhibit 99.2 CERTIFICATION I, Greg Guyatt, certify that: 1. I have reviewed this annual report on Form 40-F of Organigram Holdings Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
December 20, 2024	EX-99.11	Organigram Reports Fourth Quarter and Fiscal 2024 Results Organigram Reports Fourth Quarter and Fiscal 2024 Results TORONTO, ON, December 20, 2024 - This earnings release replaces the previously filed earnings release to correct errors in the outstanding share data tables under the heading “CAPITAL STRUCTURE”.
December 20, 2024	EX-99.1	CERTIFICATION EX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Exhibit 99.1 CERTIFICATION I, Beena Goldenberg, certify that: 1. I have reviewed this annual report on Form 40-F of Organigram Holdings Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such state
December 20, 2024	EX-99.3	CERTIFICATION PURSUANT TO 18 U.S.C. s.1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 CERTIFICATION PURSUANT TO 18 U.S.C. s.1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Organigram Holdings Inc. (the "Company") on Form 40-F for the period ended September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Beena Goldenberg, Chief Executive Officer of the Company, cert
December 20, 2024	EX-99.5	Fiscal 2024 NOTE TO READER This Management’s Discussion and Analysis for the year ended September 30, 2024 is being refiled to correct errors in the outstanding share data table on page 34.
December 18, 2024	EX-99.8	Consent of Independent Registered Public Accounting Firm The Board of Directors of Organigram Holdings Inc. We consent to the use of: • Our report dated December 18, 2024, on the consolidated financial statements of Organigram Holdings Inc. (the “Com pkfconsent Consent of Independent Registered Public Accounting Firm The Board of Directors of Organigram Holdings Inc.
December 18, 2024	EX-99.2	CERTIFICATION Exhibit 99.2 CERTIFICATION I, Greg Guyatt, certify that: 1. I have reviewed this annual report on Form 40-F of Organigram Holdings Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
December 18, 2024	EX-99.9	KPMG LLP 100 New Park Place, Suite 1400 Vaughan, ON L4K 0J3 Tel 905-265 5900 Fax 905-265 6390 www.kpmg.ca KPMG LLP, an Ontario limited liability partnership and member firm of the KPMG global organization of independent member firms affiliated with K kpmgconsent KPMG LLP 100 New Park Place, Suite 1400 Vaughan, ON L4K 0J3 Tel 905-265 5900 Fax 905-265 6390 www.
December 18, 2024	EX-99.11	ORGANIGRAM HOLDINGS INC. Annual Report Electric Lemon JOLTS (1ct) Red Razz Chiller SONICS (2ct) THCV Super Sativa Oil (30 ml) A mainstream brand focused on truly innovative products. SHRED Captain Kush 7g pre-milled flower, SHRED Gnarberry Dartz, SHR exhibit9911-annualreport ORGANIGRAM HOLDINGS INC. Annual Report Electric Lemon JOLTS (1ct) Red Razz Chiller SONICS (2ct) THCV Super Sativa Oil (30 ml) A mainstream brand focused on truly innovative products. SHRED Captain Kush 7g pre-milled flower, SHRED Gnarberry Dartz, SHRED X Tropic Thunder Heavies, SHRED’ems Wild Berry Blaze gummies, SHRED X Blueberry Blaster Rip-Strip hash 2 g, SHRED’ems Shar
December 18, 2024	EX-99.6	2024 ANNUAL INFORMATION FORM OF ORGANIGRAM HOLDINGS INC. For the Year Ended September 30, 2024 Dated December 11, 2024 TABLE OF CONTENTS ANNUAL INFORMATION FORM ......................................................................................... annualinformationform202 2024 ANNUAL INFORMATION FORM OF ORGANIGRAM HOLDINGS INC. For the Year Ended September 30, 2024 Dated December 11, 2024 TABLE OF CONTENTS ANNUAL INFORMATION FORM ............................................................................................................ 3 FORWARD-LOOKING STATEMENTS ............................................................................
December 18, 2024	EX-99.1	CERTIFICATION Exhibit 99.1 CERTIFICATION I, Beena Goldenberg, certify that: 1. I have reviewed this annual report on Form 40-F of Organigram Holdings Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with re
December 18, 2024	EX-99.5	Fiscal 2024 INTRODUCTION This Management’s Discussion and Analysis dated December 18, 2024 (this “MD&A”), should be read in conjunction with the audited annual consolidated financial statements (the “Financial Statements”) of Organigram Holdings Inc.
December 18, 2024	EX-99.7	ORGANIGRAM HOLDINGS INC. (the “Corporation”) CODE OF BUSINESS CONDUCT AND ETHICS This Code of Business Conduct and Ethics (the “Code”) was adopted by the board of directors of the Corporation (the “Board”) on August 26, 2019 and last reviewed and rev ORGANIGRAM HOLDINGS INC. (the “Corporation”) CODE OF BUSINESS CONDUCT AND ETHICS This Code of Business Conduct and Ethics (the “Code”) was adopted by the board of directors of the Corporation (the “Board”) on August 26, 2019 and last reviewed and revised on September 26, 2024. The objective of this Code is to provide guidelines for maintaining the integrity, reputation, honesty, objectivity and im
December 18, 2024	EX-99.3	CERTIFICATION PURSUANT TO 18 U.S.C. s.1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 CERTIFICATION PURSUANT TO 18 U.S.C. s.1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Organigram Holdings Inc. (the "Company") on Form 40-F for the period ended September 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Beena Goldenberg, Chief Executive Officer of the Company, cert
December 18, 2024	40-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13(A) OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2024 Commission File Number 001-38885 ORGANIGRAM HOLDINGS INC. (Exact name of Registrant as specif
December 18, 2024	EX-97.1	ORGANIGRAM HOLDINGS INC. (the “Corporation” or “Organigram”) POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED INCENTIVE-BASED COMPENSATION This Policy for the Recovery of Erroneously Awarded Inventive-Based Compensation (the “Policy”) was reviewed by t ORGANIGRAM HOLDINGS INC. (the “Corporation” or “Organigram”) POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED INCENTIVE-BASED COMPENSATION This Policy for the Recovery of Erroneously Awarded Inventive-Based Compensation (the “Policy”) was reviewed by the board of directors (the “Board”) of the Corporation on September 26, 2024 (the “Effective Date”). Purpose This Policy has been adopted by the Board
December 18, 2024	EX-99.10	Organigram Reports Fourth Quarter and Fiscal 2024 Results Organigram Reports Fourth Quarter and Fiscal 2024 Results •Fiscal 2024 net revenue of $159.
December 18, 2024	EX-99.4	TABLE OF CONTENTS Management’s Responsibility for the Financial Statements 1 Independent Auditor's Reports 2 – 9 Consolidated Statements of Financial Position 10 Consolidated Statements of Operations and Comprehensive Loss 11 Consolidated Statements TABLE OF CONTENTS Management’s Responsibility for the Financial Statements 1 Independent Auditor's Reports 2 – 9 Consolidated Statements of Financial Position 10 Consolidated Statements of Operations and Comprehensive Loss 11 Consolidated Statements of Changes in Equity 12 Consolidated Statements of Cash Flows 13 Notes to the Consolidated Financial Statements 14 – 43 December 18, 2024 Management’s Responsibility for the Financial Statements The accompanying consolidated financial statements of Organigram Holdings Inc.
December 17, 2024	EX-99.1	FORM 51-102F3 MATERIAL CHANGE REPORT FORM 51-102F3 MATERIAL CHANGE REPORT ITEM 1 - Name and Address of Company Organigram Holdings Inc.
December 17, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addre
December 17, 2024	EX-99.2	SHARE PURCHASE AGREEMENT DECEMBER 6, 2024 TABLE OF CONTENTS SHARE PURCHASE AGREEMENT DECEMBER 6, 2024 TABLE OF CONTENTS Page ARTICLE 1 INTERPRETATION 1 1.
December 11, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addre
December 11, 2024	EX-99.1	Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024 Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024 TORONTO-(BUSINESS WIRE)—December 11, 2024 -Organigram Holdings Inc.
December 10, 2024	SC 13D/A	OGI / Organigram Holdings Inc. / BT DE Investments Inc. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4) ORGANIGRAM HOLDINGS, INC. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 68620P101 (CUSIP Number) Anthony B. Petitt BT DE Investments Inc. 103 Foulk Road, Suite 111 Wilmington, Delaware 19803 (302) 656-1950 With a cop
December 6, 2024	EX-99.1	Organigram Acquires Motif, Becoming Canada’s Largest Cannabis Company by Market Share Transformational Acquisition Results in Cannabis Pure Play Leader, Coast-to-Coast Geographic Strength and Proven Excellence in Consumer-Focused Innovation, Cultivat Organigram Acquires Motif, Becoming Canada’s Largest Cannabis Company by Market Share Transformational Acquisition Results in Cannabis Pure Play Leader, Coast-to-Coast Geographic Strength and Proven Excellence in Consumer-Focused Innovation, Cultivation, Product Development, Extraction and Manufacturing • Combination results in #1 market share position in the Canadian recreational cannabis market1
December 6, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addre
November 26, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addre
November 26, 2024	EX-99.1	Organigram Launches FAST™ Nanoemulsion Gummies Organigram Launches FAST™ Nanoemulsion Gummies •Company Continues to Lead in Innovation with Launch of Edison Sonics Gummies Featuring Groundbreaking FAST™ Nanoemulsion Technology •Clinically Proven to Deliver up to ~50% Faster Onset, Improved Bioavailability and Nearly Double the Cannabinoid Delivery at Peak Effect Toronto, Ontario – November 26, 2024 - Organigram Holdings Inc.
September 3, 2024	EX-99	Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment TORONTO, Ontario – September 3, 2024 – Organigram Holdings Inc.
September 3, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number: 001- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addr
September 3, 2024	SC 13D/A	OGI / Organigram Holdings Inc. / BT DE Investments Inc. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4) ORGANIGRAM HOLDINGS, INC. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 68620P101 (CUSIP Number) Anthony B. Petitt BT DE Investments Inc. 103 Foulk Road, Suite 111 Wilmington, Delaware 19803 (302) 656-1950 With a cop
August 13, 2024	EX-99.2	TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss) 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed C TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Income (Loss) 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidated Interim Statements of Cash Flows 4 Notes to the Condensed Consolidated Interim Financial Statements 5 – 18 ORGANIGRAM HOLDINGS INC.
August 13, 2024	EX-99.1	JUNE 30, 2024 INTRODUCTION This Management’s Discussion and Analysis dated August 13, 2024 (this “MD&A”), should be read in conjunction with the unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) of Organigram Holdings Inc.
August 13, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-388 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address
August 13, 2024	EX-99.5	Organigram Reports Third Quarter Fiscal 2024 Results Organigram Reports Third Quarter Fiscal 2024 Results •Net revenue of $41.1 million increased 25% over the prior year period •Adjusted EBITDA1 of $3.5 million versus $(2.9) million over the prior year period •Established European foothold with a strategic investment in Sanity Group, a leading German cannabis company •Completed landmark clinical study on FAST™ nanoemulsion technology showing faster
August 13, 2024	EX-99.3	Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Beena Goldenberg, Chief Executive Officer of Organigram Holdings Inc.
August 13, 2024	EX-99.4	Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Greg Guyatt, Chief Financial Officer of Organigram Holdings Inc.
August 7, 2024	EX-99.1	Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology FAST™ Nanoemulsion Technology Expected to be a Competitive Advantage for Organigram’s Ingestible Portfolio Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology FAST™ Nanoemulsion Technology Expected to be a Competitive Advantage for Organigram’s Ingestible Portfolio Toronto, Ontario, August 7, 2024 – Organigram Holdings Inc.
August 7, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-388 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address
August 6, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-388 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address
August 6, 2024	EX-99	Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024 Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024 TORONTO-(BUSINESS WIRE)—August 6, 2024 -Organigram Holdings Inc.
July 29, 2024	EX-99.1	Organigram Announces Appointment of Craig Harris to Board of Directors Organigram Announces Appointment of Craig Harris to Board of Directors TORONTO, July 29, 2024 - Organigram Holdings Inc.
July 29, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month July 2024 Commission File Number: 001-38885 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month July 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of p
July 24, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month July 2024 Commission File Number: 001-38885 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month July 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of p
July 24, 2024	EX-99.1	Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos •The partial third tranche investment is expected to enable Organigram to expand its product portfolio, addressing consumer demand for unique and differentiated aromas and flavours.
July 12, 2024	EX-99.1	NOTICE OF CHANGE OF AUDITOR (National Instrument 51-102) NOTICE OF CHANGE OF AUDITOR (National Instrument 51-102) TO: PKF O’Connor Davies, LLP (“Successor Auditor”) AND TO: KPMG LLP (“Predecessor Auditor”) AND TO: Ontario Securities Commission New Brunswick Financial and Consumer Services Commission British Columbia Securities Commission Alberta Securities Commission Financial and Consumer Affairs Authority of Saskatchewan The Manitoba Securities Commis
July 12, 2024	EX-99.2	KPMG LLP, an Ontario limited liability partnership and member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. KPMG Canada provides services t KPMG LLP 100 New Park Place, Suite 1400 Vaughan, ON L4K 0J3 Tel 905-265 5900 Fax 905-265 6390 www.
July 12, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address o
July 12, 2024	EX-99.3	July 5, 2024 July 5, 2024 Ontario Securities Commission New Brunswick Financial and Consumer Services Commission British Columbia Securities Commission Alberta Securities Commission Financial and Consumer Affairs Authority of Saskatchewan The Manitoba Securities Commission Autorité des marchés financiers Nova Scotia Securities Commission Office of the Superintendent of Securities, Government of Prince Edward I
June 25, 2024	EX-99.1	Organigram Invests in Sanity Group, a Leading German Cannabis Company Second “Jupiter” investment strengthens Organigram’s European access, including to the high-growth market of Germany Organigram Invests in Sanity Group, a Leading German Cannabis Company Second “Jupiter” investment strengthens Organigram’s European access, including to the high-growth market of Germany Highlights: •Concurrent to the investment, Organigram and Sanity Group have entered into a new supply agreement to include significantly higher volumes and the intention to work together on the commercialization of Organigram’s brands and intellectual property (IP) in Germany.
June 25, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month June 2024 Commission File Number: 001-38885 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month June 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of p
May 28, 2024	EX-99.1	Organigram Signs Three Year Supply Agreement with Avida Medical in UK Organigram Signs Three Year Supply Agreement with Avida Medical in UK •Over a three-year period, Organigram expects to supply 1,700 kilograms of high-quality medical cannabis flower to Avida Medical, with 500 kilograms expected to be delivered in the first year of the agreement.
May 28, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of
May 14, 2024	EX-99.3	Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Beena Goldenberg, Chief Executive Officer of Organigram Holdings Inc.
May 14, 2024	EX-99.5	Organigram Reports Second Quarter Fiscal 2024 Results Organigram Reports Second Quarter Fiscal 2024 Results •21% growth in recreational net revenue year-over-year •First Jupiter private placement tranche closed adding $41.
May 14, 2024	EX-99.4	Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Greg Guyatt, Chief Financial Officer of Organigram Holdings Inc.
May 14, 2024	EX-99.1	MARCH 31, 2024 INTRODUCTION This Management’s Discussion and Analysis dated May 14, 2024 (this “MD&A”), should be read in conjunction with the unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) of Organigram Holdings Inc.
May 14, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address of
May 14, 2024	EX-99.2	TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Loss 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidat TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Loss 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidated Interim Statements of Cash Flows 4 Notes to the Condensed Consolidated Interim Financial Statements 5 – 17 ORGANIGRAM HOLDINGS INC.
May 8, 2024	EX-99.1	Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024 Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024 TORONTO-(BUSINESS WIRE)—May 8, 2024 -Organigram Holdings Inc.
May 8, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address of
April 25, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-3888 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address
April 25, 2024	EX-99.2	KPMG LLP KPMG LLP 100 New Park Place, Suite 1400 ” 100 New Park Place, Suite 1400 Vaughan, ON L4K 0J3 Tel 905-265 5900 Fax 905-265 6390 www.
April 25, 2024	EX-99.1	NOTICE OF CHANGE OF AUDITOR (National Instrument 51-102) NOTICE OF CHANGE OF AUDITOR (National Instrument 51-102) TO: KPMG LLP AND TO: Ontario Securities Commission New Brunswick Financial and Consumer Services Commission British Columbia Securities Commission Alberta Securities Commission Financial and Consumer Affairs Authority of Saskatchewan The Manitoba Securities Commission Autorité des marchés financiers Nova Scotia Securities Commission Office o
April 8, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-3888 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address
April 8, 2024	EX-99	Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year The fifth annual Report on Business editorial benchmark identifies top-level Canadian businesses with the highest execut Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year The fifth annual Report on Business editorial benchmark identifies top-level Canadian businesses with the highest executive gender diversity.
April 3, 2024	EX-99.1	FORM 51-102F3 MATERIAL CHANGE REPORT FORM 51-102F3 MATERIAL CHANGE REPORT Item One - Name and Address of Company Organigram Holdings Inc.
April 3, 2024	EX-99.2	Organigram's Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales Success of the brand owed to ongoing pipeline of innovative products designed to delight consumers. Organigram's Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales Success of the brand owed to ongoing pipeline of innovative products designed to delight consumers.
April 3, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File No. 001-38885 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File No. 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H IJ8 (Address of p
April 2, 2024	EX-99.1	ORGANIGRAM HOLDINGS INC. as the Corporation TSX TRUST COMPANY as the Warrant Agent Execution Version [Certain portions of this exhibit have been redacted as they are both not material and are of the type of information that the Company treats as private or confidential.
April 2, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File No. 001-38885 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File No. 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H IJ8 (Address of p
April 2, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File No. 001-38885 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File No. 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H IJ8 (Address of p
April 2, 2024	EX-99.1	Organigram Successfully Closes Previously Announced Underwritten Public Offering Including over-allotment Company raises C$28.8 million in gross proceeds improving already strong balance sheet Organigram Successfully Closes Previously Announced Underwritten Public Offering Including over-allotment Company raises C$28.
March 28, 2024	SUPPL	PROSPECTUS SUPPLEMENT (to the Short Form Base Shelf Prospectus dated October 6, 2023) Filed Pursuant to General Instruction II.L of Form F-10 File No. 333-274686 No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise. This prospectus supplement, together with the short form base shelf prospectus to which it relates dated October 6, 2023, as amended or supplemented, and each document incorporated or deemed to be inc
March 28, 2024	EX-99.1	UNDERWRITING AGREEMENT [Certain portions of this exhibit have been redacted as they are both not material and are of the type of information that the Company treats as private or confidential.
March 28, 2024	EX-99.2	March 27, 2024 March 27, 2024 To: The United States Securities and Exchange Commission Organigram Holdings Inc.
March 28, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File No. 001-38885 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File No. 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H IJ8 (Address of p
March 27, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File No. 001-38885 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File No. 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H IJ8 (Address of p
March 27, 2024	FWP	Indicative Term Sheet $25 million Treasury Offering Of Equity Units March 26, 2024 Filed pursuant to Rule 433 Registration Statement No. 333-274686 Issuer Free Writing Prospectus dated March 26, 2024 Relating to Prospectus dated October 6, 2023 Indicative Term Sheet $25 million Treasury Offering Of Equity Units March 26, 2024 The Units (as hereinafter defined) will be offered by way of a prospectus supplement to a final base shelf prospectus in each of the provinces and territor
March 27, 2024	EX-99.1	Organigram Announces Pricing of Overnight Marketed Public Offering Organigram Announces Pricing of Overnight Marketed Public Offering TORONTO-(BUSINESS WIRE)-March 27, 2024-Organigram Holdings Inc.
March 27, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File No. 001-38885 OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File No. 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H IJ8 (Address of p
March 27, 2024	EX-99.1	Organigram Announces Launch of Overnight Marketed Public Offering Organigram Announces Launch of Overnight Marketed Public Offering TORONTO-(BUSINESS WIRE)-March 26, 2024-Organigram Holdings Inc.
March 27, 2024	FWP	Term Sheet Approximately $25 million Treasury Offering Of Equity Units March 27, 2024 Filed pursuant to Rule 433 Registration Statement No. 333-274686 Issuer Free Writing Prospectus dated March 27, 2024 Relating to Prospectus dated October 6, 2023 Term Sheet Approximately $25 million Treasury Offering Of Equity Units March 27, 2024 The Units (as hereinafter defined) will be offered by way of a prospectus supplement to a final base shelf prospectus in each of the provinces and terri
March 26, 2024	EX-99.1	Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment North Carolina-based Open Book Extracts is a leading ingredient provider, product formulator and manufacturer of hemp-derived extracts and products. Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment North Carolina-based Open Book Extracts is a leading ingredient provider, product formulator and manufacturer of hemp-derived extracts and products. Toronto, Ontario – March 26, 2024 - Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) is pleased to announce a US $2 million
March 26, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-3888 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address
March 25, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-3888 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address
March 25, 2024	EX-99.1	Organigram Receives Health Canada’s Final Redetermination on Jolts Organigram Receives Health Canada’s Final Redetermination on Jolts TORONTO-(BUSINESS WIRE)—March 22, 2024 - Organigram Holdings Inc.
February 28, 2024	EX-99.1	Organigram Applauds the Standing Committee on Finance’s Recommendation on Excise Duty Revised Excise Framework Remains One of the Most Critical Reforms Required to Ensure the Long-Term Viability of the Cannabis Industry Organigram Applauds the Standing Committee on Finance’s Recommendation on Excise Duty Revised Excise Framework Remains One of the Most Critical Reforms Required to Ensure the Long-Term Viability of the Cannabis Industry Toronto, Ontario – February 28, 2024 - Organigram Holdings Inc.
February 28, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addre
February 13, 2024	EX-99.4	Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Greg Guyatt, Chief Financial Officer of Organigram Holdings Inc.
February 13, 2024	EX-99.1	DECEMBER 31, 2023 INTRODUCTION This Management’s Discussion and Analysis dated February 13, 2024 (this “MD&A”), should be read in conjunction with the unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) of Organigram Holdings Inc.
February 13, 2024	EX-99.2	TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss) Income 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed C TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive (Loss) Income 2 Condensed Consolidated Interim Statements of Changes in Equity 3 Condensed Consolidated Interim Statements of Cash Flows 4 Notes to the Condensed Consolidated Interim Financial Statements 5 – 15 ORGANIGRAM HOLDINGS INC.
February 13, 2024	EX-99.3	Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Beena Goldenberg, Chief Executive Officer of Organigram Holdings Inc.
February 13, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Addre
February 13, 2024	EX-99.5	Organigram Reports First Quarter Fiscal 2024 Results Achieved positive cash flow from operations, solidified #2 market position in Canada among licensed producers, significantly improved margins sequentially quarter-over-quarter, and closed first $41 Organigram Reports First Quarter Fiscal 2024 Results Achieved positive cash flow from operations, solidified #2 market position in Canada among licensed producers, significantly improved margins sequentially quarter-over-quarter, and closed first $41.
February 7, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addre
February 7, 2024	EX-99.1	Organigram to Report First Quarter Fiscal 2024 Results on February 13, 2024 Exhibit 99.1 Organigram to Report First Quarter Fiscal 2024 Results on February 13, 2024 TORONTO-(BUSINESS WIRE)-February 7, 2024-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2024 ended December
January 31, 2024	EX-99.1	Organigram Completes First Shipment to Germany, Extending its International Reach Exhibit 99.1 Organigram Completes First Shipment to Germany, Extending its International Reach TORONTO-(BUSINESS WIRE)-January 31, 2024-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis today announced that it has sent its first shipment of bulk dried flower to the medical division of German cannabis company, Sanity Group, a
January 31, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addres
January 25, 2024	EX-99.1	AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT BT DE INVESTMENTS INC. ORGANIGRAM HOLDINGS INC. January 23, 2024 EX-99.1 2 d30296dex991.htm EX-99.1 Exhibit 99.1 Confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934 has been requested for the redacted portions of this exhibit, and such confidential portions have been omitted and filed separately with the U.S. Securities and Exchange Commission. Execution Version AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT between BT DE INV
January 25, 2024	SC 13D/A	OGI / Organigram Holdings Inc. / BT DE Investments Inc. - SC 13D/A Activist Investment SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3) ORGANIGRAM HOLDINGS, INC. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 68620P101 (CUSIP Number) Anthony B. Petitt BT DE Investments Inc. 103 Foulk Road, Suite 111 Wilmington, Delaware 19803 (302) 656-1950 With a cop
January 24, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addres
January 24, 2024	EX-99.1	AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT BT DE INVESTMENTS INC. ORGANIGRAM HOLDINGS INC. January 23, 2024 TABLE OF CONTENTS AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT between BT DE INVESTMENTS INC. and ORGANIGRAM HOLDINGS INC. January 23, 2024 TABLE OF CONTENTS ARTICLE 1 DEFINITIONS AND INTERPRETATION Section 1.1 Definitions. 1 Section 1.2 Gender and Number. 9 Section 1.3 Headings, etc. 9 Section 1.4 Currency. 9 Section 1.5 Certain Phrases, etc. 9 Section 1.6 Accounting Terms. 9 Section 1.7 Schedules. 9 Section 1.8
January 24, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addres
January 24, 2024	EX-99.1	Organigram Announces the First Tranche Closing from BAT Investment Exhibit 99.1 Organigram Announces the First Tranche Closing from BAT Investment TORONTO-(BUSINESS WIRE)-January 24, 2024-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that it has closed the first of three tranches of the previously announced C$124,559,674 follow-on strategic equity investment (the “Inves
January 19, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addres
January 19, 2024	EX-99.3	Organigram Holdings Inc. Corporate name / Dénomination sociale Corporation number / Numéro de société EX-99.3 Exhibit 99.3 Certificate of Amendment Certificat de modification Canada Business Corporations Act Loi canadienne sur les sociétés par actions Organigram Holdings Inc. Corporate name / Dénomination sociale 969981-3 Corporation number / Numéro de société I HEREBY CERTIFY that the articles of the above-named corporation are amended under section 178 of the Canada Business Corporations Act as
January 19, 2024	EX-99.1	Organigram Announces Appointment of Karina Gehring to Board of Directors Exhibit 99.1 Organigram Announces Appointment of Karina Gehring to Board of Directors TORONTO-(BUSINESS WIRE)-January 19, 2024-Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), announced the appointment of Karina Gehring to the Organigram Board of Directors at the Company’s annual general and special meeting held on January 18, 2024. “We are thrilled to welcome Kar
January 19, 2024	EX-99.2	ORGANIGRAM HOLDINGS INC. (the “Corporation”) Annual General and Special Meeting of Shareholders Held on January 18, 2024 REPORT OF VOTING RESULTS EX-99.2 Exhibit 99.2 ORGANIGRAM HOLDINGS INC. (the “Corporation”) Annual General and Special Meeting of Shareholders Held on January 18, 2024 REPORT OF VOTING RESULTS Pursuant to section 11.3 of National Instrument 51-102 – Continuous Disclosure Obligations, this report describes the matters decided at the 2023 annual general and special meeting of shareholders of the Corporation held on January 1
January 19, 2024	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2024 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Ad
January 19, 2024	EX-99.1	Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT EX-99.1 Exhibit 99.1 Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of C$124.6 Million Investment from BAT TORONTO, Ontario – (BUSINESS WIRE) – January 18, 2024 – Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders (the “Sharehold
December 29, 2023	EX-99.1	Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting Exhibit 99.1 Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting Special Meeting to Approve $124.6 Million Investment from BAT at $3.2203/share and Creation of “Jupiter” Strategic Investment Pool TORONTO-(BUSINESS WIRE)-December 29, 2023-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading li
December 29, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addre
December 27, 2023	EX-99.4	AMENDMENT TO SUBSCRIPTION AGREEMENT Exhibit 99.4 [Certain portions of this exhibit have been redacted as they are both not material and are of the type of information that the Company treats as private or confidential. Redacted information is denoted by “[*]” in this exhibit. The Company agrees to furnish supplementally an unredacted copy of the exhibit to the SEC upon its request.] AMENDMENT TO SUBSCRIPTION AGREEMENT This AMENDING
December 27, 2023	EX-99.1	NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on January 18, 2024 MANAGEMENT INFORMATION CIRCULAR Dated: December 20, 2023 Exhibit 99.1 NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS to be held on January 18, 2024 and MANAGEMENT INFORMATION CIRCULAR Dated: December 20, 2023 Message to Shareholders Dear Shareholders, The board of directors (the “Board”) of Organigram Holdings Inc. (the “Company” or “Organigram”) is pleased to invite you to our annual general and special meeting (the “Meeting”) of the hold
December 27, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-3 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (A
December 27, 2023	EX-99.3	TSX TRUST Virtual Meeting Guide 1/2 Issuer Name ORGANIGRAM HOLDINGS INC. Meeting Date THURSDAY, JANUARY 18, 2024 Time 10:00 AM ET This year we will be conducting a virtual meeting, giving you the opportunity to attend the meeting online, using your s Exhibit 99.3 TSX TRUST Virtual Meeting Guide 1/2 Issuer Name ORGANIGRAM HOLDINGS INC. Meeting Date THURSDAY, JANUARY 18, 2024 Time 10:00 AM ET This year we will be conducting a virtual meeting, giving you the opportunity to attend the meeting online, using your smartphone, tablet or computer. You will be able to view a live webcast of the Meeting, ask questions and submit your votes in real time (
December 27, 2023	EX-99.2	- SEE VOTING GUIDELINES ON REVERSE - Exhibit 99.2 ORGANIGRAM HOLDINGS INC (“Organigram Holdings Inc.”) Annual General and Special Meeting Jan. 18, 2024 at 10:00 AM (Canada/Eastern Standard) Virtual Meeting at 10am EST (the “Meeting”) Proxy Voting – Guidelines and Conditions 1. THIS PROXY IS SOLICITED BY OR ON BEHALF OF THE MANAGEMENT OF ORGANIGRAM HOLDINGS INC.. 2. THIS PROXY SHOULD BE READ IN CONJUNCTION WITH THE MEETING MATERIALS P
December 19, 2023	EX-99.7	ORGANIGRAM HOLDINGS INC. (the “Corporation”) CODE OF BUSINESS CONDUCT AND ETHICS This Code of Business Conduct and Ethics (the “Code”) was adopted by the board of directors of the Corporation (the “Board”) on August 26, 2019 and last reviewed and rev ORGANIGRAM HOLDINGS INC. (the “Corporation”) CODE OF BUSINESS CONDUCT AND ETHICS This Code of Business Conduct and Ethics (the “Code”) was adopted by the board of directors of the Corporation (the “Board”) on August 26, 2019 and last reviewed and revised on September 18, 2023. The objective of this Code is to provide guidelines for maintaining the integrity, reputation, honesty, objectivity and im
December 19, 2023	EX-99.9	ORGANIGRAM HOLDINGS INC. Annual Report Limelight 3.5g dried flower Edison JOLTS – Electric Lemon Limelight + Cobra Milk Pinners Combo Pack A mainstream brand focused on pre-rolls and true innovation. SHRED Funk Master 7g pre-milled flower, SHRED Gnar ORGANIGRAM HOLDINGS INC. Annual Report Limelight 3.5g dried flower Edison JOLTS – Electric Lemon Limelight + Cobra Milk Pinners Combo Pack A mainstream brand focused on pre-rolls and true innovation. SHRED Funk Master 7g pre-milled flower, SHRED Gnarberry Dartz, SHRED X Tropic Thunder Heavies, SHRED’ems Wild Berry Blaze gummies, SHRED X Blueberry Blaster Rip-Strip Hash 2 g An uplifting & vibrant v
December 19, 2023	EX-97.1	ORGANIGRAM HOLDINGS INC. (the “Corporation” or “Organigram”) POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED INCENTIVE-BASED COMPENSATION This Policy for the Recovery of Erroneously Awarded Inventive-Based Compensation (the “Policy”) was adopted by th ORGANIGRAM HOLDINGS INC. (the “Corporation” or “Organigram”) POLICY FOR THE RECOVERY OF ERRONEOUSLY AWARDED INCENTIVE-BASED COMPENSATION This Policy for the Recovery of Erroneously Awarded Inventive-Based Compensation (the “Policy”) was adopted by the board of directors (the “Board”) of the Corporation on November 30, 2023 (the “Effective Date”). Purpose This Policy has been adopted by the Board i
December 19, 2023	EX-99.5	Fiscal 2023 INTRODUCTION This Management’s Discussion and Analysis dated December 19, 2023 (this “MD&A”), should be read in conjunction with the audited annual consolidated financial statements (the “Financial Statements”) of Organigram Holdings Inc.
December 19, 2023	EX-99.4	TABLE OF CONTENTS Management’s Responsibility for the Financial Statements 1 Independent Auditor's Reports 2 – 7 Consolidated Statements of Financial Position 8 Consolidated Statements of Operations and Comprehensive Loss 9 Consolidated Statements of TABLE OF CONTENTS Management’s Responsibility for the Financial Statements 1 Independent Auditor's Reports 2 – 7 Consolidated Statements of Financial Position 8 Consolidated Statements of Operations and Comprehensive Loss 9 Consolidated Statements of Changes in Equity 10 Consolidated Statements of Cash Flows 11 Notes to the Consolidated Financial Statements 12 – 41 December 19, 2023 Management’s Responsibility for the Financial Statements The accompanying consolidated financial statements of Organigram Holdings Inc.
December 19, 2023	EX-99.10	Organigram Reports Fiscal 2023 Results1 Organigram Reports Fiscal 2023 Results1 •Domestic share growth in several key categories continues to be driven by innovation excellence and industry-leading R&D.
December 19, 2023	EX-99.8	KPMG LLP 100 New Park Place, Suite 1400 Vaughan, ON L4K 0J3 Tel 905-265 5900 Fax 905-265 6390 www.kpmg.ca Consent of Independent Registered Public Accounting Firm The Board of Directors Organigram Holdings Inc. We consent to the use of:  our report KPMG LLP 100 New Park Place, Suite 1400 Vaughan, ON L4K 0J3 Tel 905-265 5900 Fax 905-265 6390 www.
December 19, 2023	EX-99.3	CERTIFICATION PURSUANT TO 18 U.S.C. s.1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 CERTIFICATION PURSUANT TO 18 U.S.C. s.1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Organigram Holdings Inc. (the "Company") on Form 40-F for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Beena Goldenberg, Chief Executive Officer of the Company, cer
December 19, 2023	EX-99.2	CERTIFICATION Exhibit 99.2 CERTIFICATION I, Paolo De Luca, certify that: 1. I have reviewed this annual report on Form 40-F of Organigram Holdings Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respe
December 19, 2023	40-F	UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13(A) OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2023 Commission File Number 001-38885 ORGANIGRAM HOLDINGS INC. (Exact name of Registrant as specif
December 19, 2023	EX-99.6	2023 ANNUAL INFORMATION FORM OF ORGANIGRAM HOLDINGS INC. For the Thirteen Month Period Ended September 30, 2023 Dated December 15, 2023 TABLE OF CONTENTS ANNUAL INFORMATION FORM ........................................................................ 2023 ANNUAL INFORMATION FORM OF ORGANIGRAM HOLDINGS INC. For the Thirteen Month Period Ended September 30, 2023 Dated December 15, 2023 TABLE OF CONTENTS ANNUAL INFORMATION FORM ............................................................................................................ 1 FORWARD-LOOKING STATEMENTS ....................................................................................
December 19, 2023	EX-99.1	CERTIFICATION Exhibit 99.1 CERTIFICATION I, Beena Goldenberg, certify that: 1. I have reviewed this annual report on Form 40-F of Organigram Holdings Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with re
December 18, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addre
December 18, 2023	EX-99.1	Organigram Announces Appointment of Greg Guyatt as Chief Financial Officer Exhibit 99.1 Organigram Announces Appointment of Greg Guyatt as Chief Financial Officer TORONTO-(BUSINESS WIRE)-December 18, 2023-Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) is pleased to announce that Greg Guyatt CPA, CA, formerly of Phoena Holdings Inc. (“Phoena”), has been appointed to the role of Chief Financial Officer effective January 8, 2024. Mr. Guyat
December 14, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addre
December 14, 2023	EX-99.1	Organigram to Report Fourth Quarter and Fiscal 2023 Results on December 19, 2023 Exhibit 99.1 Organigram to Report Fourth Quarter and Fiscal 2023 Results on December 19, 2023 TORONTO-(BUSINESS WIRE)-December 14, 2023-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and fiscal 2023 ende
December 13, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addre
December 13, 2023	EX-99.1	Organigram Wins KIND Magazine’s Innovation of the Year for SHRED X Rip-Strips Hash Exhibit 99.1 Organigram Wins KIND Magazine’s Innovation of the Year for SHRED X Rip-Strips Hash Organigram wins “Innovation of the Year” two years in a row cementing its reputation as a disruptive leader in the cannabis sector TORONTO-(BUSINESS WIRE)-December 13, 2023-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of a leading licensed producer of cannabis (the “Company” or
November 28, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addre
November 28, 2023	EX-99.1	Organigram Increases Investment in Phylos After Successful Milestone Achievement Exhibit 99.1 Organigram Increases Investment in Phylos After Successful Milestone Achievement Organigram to advance the conversion of its grow rooms with custom designed, F1 Hybrid seeds Organigram expects to soon be able to begin low-cost production of high-potency, terpene-rich cultivars destined for various products and blends across its brand portfolio. Organigram is on track to convert more t
November 15, 2023	EX-99.1	FORM 51-102F3 MATERIAL CHANGE REPORT Exhibit 99.1 FORM 51-102F3 MATERIAL CHANGE REPORT Item One – Name and Address of Company Organigram Holdings Inc. (the “Company”) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 Item Two – Date of Material Change November 5, 2023 Item Three – News Release The news release reporting the material change described in this report was issued in Toronto, Ontario on November 6, 2023 (th
November 15, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addre
November 13, 2023	EX-99.1	Organigram Announces Interim Chief Financial Officer Exhibit 99.1 Organigram Announces Interim Chief Financial Officer TORONTO-(BUSINESS WIRE)-November 10, 2023-The Board of Directors (the “Board”) of Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) today announced that Derrick West has informed Organigram that he will transition away from his role as Chief Financial Officer (“CFO”) in order to take time to focus on
November 13, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addre
November 8, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File No. 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File No. 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H IJ8 (Address o
November 8, 2023	EX-99.1	SUBSCRIPTION AGREEMENT BT DE INVESTMENTS INC. ORGANIGRAM HOLDINGS INC. SUBSCRIPTION AGREEMENT between BT DE INVESTMENTS INC. and ORGANIGRAM HOLDINGS INC. November 5, 2023 [Certain portions of this exhibit have been redacted as they are both not material and are of the type of information that the Company treats as private or confidential. Redacted information is denoted by "[*]" in this exhibit. The Company agrees to furnish supplementally an unredacted copy of the e
November 8, 2023	SC 13D/A	OGI / OrganiGram Holdings Inc. / BT DE Investments Inc. - SC 13D/A Activist Investment SC 13D/A 1 d384046dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) ORGANIGRAM HOLDINGS, INC. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 68620P101 (CUSIP Number) Anthony B. Petitt BT DE Investments Inc. 103 Foulk Road, Suite 111 Wilmington, Delaware 1
November 6, 2023	EX-99.1	Organigram Announces C$124.6 Million Investment from BAT and Creation of “Jupiter” Strategic Investment Pool Exhibit 99.1 Organigram Announces C$124.6 Million Investment from BAT and Creation of “Jupiter” Strategic Investment Pool Organigram and BAT deepen partnership through C$124.6 million investment with 38.7 million shares to be issued over three tranches Organigram to use C$83.1 million of the investment to create “Jupiter,” a strategic investment pool designed to expand Organigram’s geographic foot
November 6, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number: 001-3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addre
October 18, 2023	EX-99.1	Organigram Provides Corporate Update Exhibit 99.1 Organigram Provides Corporate Update Achieves #2 Market Share Over the Last Two Months TORONTO-(BUSINESS WIRE)-October 18, 2023-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to provide a corporate update. Market Share Momentum Market share continues to be an important indicator of success for lic
October 18, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number: 001-38 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addres
October 12, 2023	EX-99.1	Organigram Holdings Inc. Files Final Base Shelf Prospectus Exhibit 99.1 Organigram Holdings Inc. Files Final Base Shelf Prospectus TORONTO-(BUSINESS WIRE)-October 11, 2023-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licenced producer of cannabis, announced today that it has obtained a receipt for a final short form base shelf prospectus (the “Base Shelf Prospectus”) filed with the securities commissions in
October 12, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number: 001-38 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addres
October 6, 2023	F-10/A	As filed with the Securities and Exchange Commission on October 6, 2023 As filed with the Securities and Exchange Commission on October 6, 2023 Registration No.
September 26, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number: 001- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addr
September 26, 2023	EX-99.1	Organigram Holdings Inc. Files Preliminary Base Shelf Prospectus Exhibit 99.1 Organigram Holdings Inc. Files Preliminary Base Shelf Prospectus TORONTO-(BUSINESS WIRE)-September 25, 2023-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licenced producer of cannabis, announced today that it has filed a preliminary short form base shelf prospectus (the “Base Shelf Prospectus”) with the securities commissions in each of
September 25, 2023	F-10	As filed with the Securities and Exchange Commission on September 25, 2023 As filed with the Securities and Exchange Commission on September 25, 2023 Registration No.
September 25, 2023	EX-7.1	Organigram Holdings Inc. as Issuer [ ] as Trustee Dated as of [ ] Organigram Holdings Inc. Reconciliation and tie between Trust Indenture Act of 1939 and Indenture, dated as of [ ] Organigram Holdings Inc. as Issuer [ ] as Trustee Indenture Dated as of [ ] Organigram Holdings Inc. Reconciliation and tie between Trust Indenture Act of 1939 and Indenture, dated as of [ ] Trust Indenture Act Section Indenture Section § 310(a)(1) 6.7 (a)(2) 6.7 (b) 6.8 § 312(b) 7.1 (c) 7.1 § 313(a) 7.2 (b)(1) 7.2 (b)(2) 7.2 (c) 7.2 (d) 7.2 § 314(a) 7.3 (a)(4) 9.4 (c)(1) 1.2 (c)(2) 1.2 (e) 1.2 §
September 25, 2023	EX-FILING FEES	Calculation of Filing Fee Table F-10 (Form Type) Organigram Holdings Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Exhibit 107 Calculation of Filing Fee Table F-10 (Form Type) Organigram Holdings Inc.
September 25, 2023	F-X	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-X APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-X APPOINTMENT OF AGENT FOR SERVICE OF PROCESS AND UNDERTAKING A. Name of issuer or person filing ("Filer"): Organigram Holdings Inc. B. (1) This is [check one]: ☒ an original filing for the Filer. ☐ an amended filing for the Filer. (2) Check the following box if you are filing the Form F-X in paper in accordance with Re
September 5, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number: 001- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Addr
September 5, 2023	EX-99.1	Organigram Announces Resignation of Board Member Exhibit 99.1 Organigram Announces Resignation of Board Member TORONTO-(BUSINESS WIRE)-September 1, 2023-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announces today that Ms. Caroline Ferland has resigned from the Board of Directors (“the Board”) effective immediately. Ms. Ferland was a board member nominee appointed by
August 28, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-388 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address
August 28, 2023	EX-99.1	Organigram Launches First Range of THCV Products Derived from Moncton-Grown Whole Flower Exhibit 99.1 Organigram Launches First Range of THCV Products Derived from Moncton-Grown Whole Flower First lineup of THCV products enabled by Organigram’s strategic investment in Phylos Bioscience TORONTO-(BUSINESS WIRE)-August 28, 2023-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to launch its first range
August 21, 2023	EX-99.1	Organigram Relaunches one of Canada’s First Cannabis Brands, Trailblazer Exhibit 99.1 Organigram Relaunches one of Canada’s First Cannabis Brands, Trailblazer Trailblazer returns to the Canadian marketplace with a new range of products TORONTO-(BUSINESS WIRE)-August 21, 2023-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the relaunch of one of Canada’s best known cannab
August 21, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-388 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address
August 15, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-388 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address
August 15, 2023	EX-99.1	Organigram to Enter the United Kingdom with Agreement to Supply Medical Cannabis to 4C LABS Exhibit 99.1 Organigram to Enter the United Kingdom with Agreement to Supply Medical Cannabis to 4C LABS Organigram to supply 4C LABS with high-quality Medical Cannabis for distribution to UK Medical Cannabis patients Organigram chosen by 4C LABS to be the preferred supplier of Medical Cannabis flower to deliver innovative new products to the UK market First year of the agreement expected to reach
August 10, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-388 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address
August 10, 2023	EX-99.1	Organigram’s Application for Judicial Review on Jolts Ingestible Extract Granted Exhibit 99.1 Organigram’s Application for Judicial Review on Jolts Ingestible Extract Granted TORONTO-(BUSINESS WIRE)-August 10, 2023-Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announced today that the Federal Court of Canada (the “Court”) has granted Organigram’s application for judicial review of a decision of Health Canada determining that the Edison Jolts
August 2, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-388 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address
August 2, 2023	EX-99.1	Organigram Launches New Tube-style Pre-rolls: SHRED Dartz and Holy Smokes Exhibit 99.1 Organigram Launches New Tube-style Pre-rolls: SHRED Dartz and Holy Smokes Both SHRED Dartz and Holy Smokes come in 10x0.4g packs and are rolled with 100% organic hemp paper providing a more natural and elevated cannabis experience TORONTO-(BUSINESS WIRE)-August 2, 2023-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of ca
July 14, 2023	EX-99.1	Illustrative Overview of Composition and Flow of Biological Assets, Inventories, and Cost of Sales INTRODUCTION This Management’s Discussion and Analysis dated July 13, 2023 (this “MD&A”), should be read in conjunction with the unaudited condensed consolidated interim financial statements (the “Interim Financial Statements”) of Organigram Holdings Inc.
July 14, 2023	EX-99.5	Organigram Reports Third Quarter Fiscal 2023 Results Year-to-date Canadian recreational business grew 10% versus prior year driven by continued focus on consumer-centric products and brands Strategic investments in Phylos and Greentank strengthen Org Organigram Reports Third Quarter Fiscal 2023 Results Year-to-date Canadian recreational business grew 10% versus prior year driven by continued focus on consumer-centric products and brands Strategic investments in Phylos and Greentank strengthen Organigram’s position as an industry leader in cannabis innovation, solidifying long-term competitive advantage HIGHLIGHTS •Recreational net revenue was $92.
July 14, 2023	EX-99.3	Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Beena Goldenberg, Chief Executive Officer of Organigram Holdings Inc.
July 14, 2023	EX-99.4	Form 52-109F2 Certification of Interim Filings Full Certificate Form 52-109F2 Certification of Interim Filings Full Certificate I, Derrick West, Chief Financial Officer of Organigram Holdings Inc.
July 14, 2023	EX-99.2	TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Loss 2 Condensed Consolidated Interim Statements of Changes in Shareholders' Equity 3 Conden TABLE OF CONTENTS Condensed Consolidated Interim Statements of Financial Position 1 Condensed Consolidated Interim Statements of Operations and Comprehensive Loss 2 Condensed Consolidated Interim Statements of Changes in Shareholders' Equity 3 Condensed Consolidated Interim Statements of Cash Flows 4 Notes to the Condensed Consolidated Interim Financial Statements 5 – 19 ORGANIGRAM HOLDINGS INC.
July 14, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario ,Canada M5H 1J8 (Address o
July 14, 2023	EX-99.6	FORM 51-102F3 MATERIAL CHANGE REPORT FORM 51-102F3 MATERIAL CHANGE REPORT Item One – Name and Address of Company Organigram Holdings Inc.
July 10, 2023	EX-99.1	Organigram to Report Third Quarter Fiscal 2023 Results on July 13, 2023 Exhibit 99.1 Organigram to Report Third Quarter Fiscal 2023 Results on July 13, 2023 TORONTO-(BUSINESS WIRE)-July 7, 2023-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its third quarter fiscal 2023 ended May 31, 2023, on
July 10, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address o
July 6, 2023	EX-99.2	ORGANIGRAM HOLDINGS INC. CERTIFICATE OF CONSOLIDATION AND ADJUSTMENT UNDER WARRANT ORGANIGRAM HOLDINGS INC. CERTIFICATE OF CONSOLIDATION AND ADJUSTMENT UNDER WARRANT INDENTURE TO: TSX Trust Company RE: Warrants issued November 12, 2020 and expiring November 12, 2023 Reference is made to the warrant indenture dated as of November 12, 2020 (the "Warrant Indenture") between Organigram Holdings Inc. (the "Corporation") and TSX Trust Company ("TSXT") pursuant to which up to 18,687,50
July 6, 2023	EX-99.4	Certificate of Amendment Canada Business Corporations Act Certificate of Amendment Canada Business Corporations Act Certificat de modification Loi canadienne surles sociétés par actions Organigram Holdings Inc.
July 6, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant's name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address o
July 6, 2023	EX-99.1	Organigram Announces Completion of Share Consolidation Organigram Announces Completion of Share Consolidation TORONTO-(BUSINESS WIRE)-July 5, 2023 - Organigram Holdings Inc.
July 6, 2023	EX-99.3	LETTER OF TRANSMITTAL WITH RESPECT TO THE COMMON SHARES OF ORGANIGRAM HOLDINGS INC. The instructions accompanying this Letter of Transmittal should be read carefully before completing this Letter of Transmittal.
June 21, 2023	EX-99.1	Organigram Announces Effective Date of Share Consolidation Exhibit 99.1 Organigram Announces Effective Date of Share Consolidation TORONTO-(BUSINESS WIRE)-June 19, 2023-Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI) announced today that its Board has approved the consolidation of the Company’s issued and outstanding common shares at a consolidation ratio of four (4) pre-consolidation common shares for every post-consolida
June 21, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address o
June 21, 2023	EX-99.1	Organigram Introduces Ultra High-THC Infused Pre-Rolls, SHRED X Heavies Exhibit 99.1 Organigram Introduces Ultra High-THC Infused Pre-Rolls, SHRED X Heavies SHRED X Heavies is one of the only infused pre-roll offerings to combine diamonds, distillate, and botanical terpenes, providing an unparalleled experience in a convenient 0.5g pre-roll. TORONTO-(BUSINESS WIRE)-June 21, 2023-Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a lead
June 21, 2023	6-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-38885 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-38885 ORGANIGRAM HOLDINGS INC. (Translation of registrant’s name into English) 145 King Street West, Suite 1400 Toronto, Ontario, Canada M5H 1J8 (Address o

OGI / Organigram Global Inc. - SEC Filings, Annual Report, Proxy Statement

Basic Stats

SEC Filings

SEC Filings (Chronological Order)

Other Listings

DE:0OG
CA:OGI	CA$2.28